This compound is an oxalate salt form of a substituted benzonitrile derivative. It is primarily used as a pharmaceutical intermediate in the manufacturing of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 717133-32-9
4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile
pharmaceutical intermediate
Citadiol hydrobromide
pharmaceutical intermediate
Citadiol hydrochloride
pharmaceutical intermediate
Methyl 4-((3R,5R,7R,8R,9S,10S,13R,14S,17R)-3-((tert-butyldimethylsilyl)oxy)-7-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
steroid intermediate for synthesis
3-Bromo-2-methoxy-6-methylpyridine
pharmaceutical research intermediate
3-BROMO-2-ISOPROPOXYPYRIDINE
Pharmaceutical intermediate for synthesis
Ethyl 2-cyano-2-phenylbutanoate
Pharmaceutical intermediate
Citadiol hemidtta, (S,S,S)-
pharmaceutical intermediate
4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile;oxalic acid
FVHFLMVLFQFEHN-UHFFFAOYSA-N
CN(C)CCCC(C1=CC=C(C=C1)F)(C2=C(C=C(C=C2)C#N)CO)O.C(=O)(C(=O)O)O
—